SAMANTHA LIEM: Open Payments
NPI 1275979312 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 42 payments from 13 companies in 2025. Trend: 2023 $1,772 · 2024 $1,531 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $376 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $177 |
| Madrigal Pharmaceuticals | 2 | $70 |
| Janssen Biotech, Inc. | 3 | $69 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
| PFIZER INC. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| VIVUS LLC | 2 | $35 |
| Lilly USA, LLC | 1 | $33 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
Products named: SKYRIZI, ENTYVIO, CREON, REZDIFFRA, TREMFYA, RINVOQ, LINZESS, VOQUEZNA.
Industry payments across IL — which companies pay providers there.
